299 related articles for article (PubMed ID: 16341044)
61. CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry.
Yuan CM; Vergilio JA; Zhao XF; Smith TK; Harris NL; Bagg A
Hum Pathol; 2005 Jul; 36(7):784-91. PubMed ID: 16084948
[TBL] [Abstract][Full Text] [Related]
62. Peripheral T-cell lymphoma with progression to a clonally related, Epstein Barr virus+, cytotoxic aggressive T-cell lymphoma: evidence for secondary EBV infection of an established malignant T-cell clone.
Langer R; Geissinger E; Rüdiger T; von Schilling C; Ott G; Mandl-Weber S; Quintanilla-Martinez L; Fend F
Am J Surg Pathol; 2010 Sep; 34(9):1382-7. PubMed ID: 20739840
[TBL] [Abstract][Full Text] [Related]
63. Pathobiology and molecular profiling of peripheral T-cell lymphomas.
de Leval L; Gaulard P
Hematology Am Soc Hematol Educ Program; 2008; ():272-9. PubMed ID: 19074096
[TBL] [Abstract][Full Text] [Related]
64. t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia.
Lierman E; Smits S; Debackere K; André M; Michaux L; Vandenberghe P
Br J Haematol; 2023 Mar; 200(5):665-668. PubMed ID: 36385372
[No Abstract] [Full Text] [Related]
65. Fine-needle aspiration biopsy of peripheral T-cell lymphomas. A cytologic and immunophenotypic study of 33 cases.
Yao JL; Cangiarella JF; Cohen JM; Chhieng DC
Cancer; 2001 Apr; 93(2):151-9. PubMed ID: 11309782
[TBL] [Abstract][Full Text] [Related]
66. Mapping of the gene for the tyrosine kinase Itk to a region of conserved synteny between mouse chromosome 11 and human chromosome 5q.
Janis EM; Siliciano JD; Isaac DD; Griffin CA; Hawkins AL; Kozak CA; Desiderio S
Genomics; 1994 Sep; 23(1):269-71. PubMed ID: 7829087
[TBL] [Abstract][Full Text] [Related]
67. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma.
Rinaldi A; Kwee I; Taborelli M; Largo C; Uccella S; Martin V; Poretti G; Gaidano G; Calabrese G; Martinelli G; Baldini L; Pruneri G; Capella C; Zucca E; Cotter FE; Cigudosa JC; Catapano CV; Tibiletti MG; Bertoni F
Br J Haematol; 2006 Feb; 132(3):303-16. PubMed ID: 16409295
[TBL] [Abstract][Full Text] [Related]
68. Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients.
Gordon BG; Weisenburger DD; Warkentin PI; Anderson J; Sanger WG; Bast M; Gnarra D; Vose JM; Bierman PJ; Armitage JO
Cancer; 1993 Jan; 71(1):257-63. PubMed ID: 8380117
[TBL] [Abstract][Full Text] [Related]
69. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
[TBL] [Abstract][Full Text] [Related]
70. Fusion of dynactin 1 to anaplastic lymphoma kinase in inflammatory myofibroblastic tumor.
Wang X; Krishnan C; Nguyen EP; Meyer KJ; Oliveira JL; Yang P; Yi ES; Erickson-Johnson MR; Yaszemski MJ; Maran A; Oliveira AM
Hum Pathol; 2012 Nov; 43(11):2047-52. PubMed ID: 22658521
[TBL] [Abstract][Full Text] [Related]
71. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
[TBL] [Abstract][Full Text] [Related]
72. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
Sandell RF; Boddicker RL; Feldman AL
Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
[TBL] [Abstract][Full Text] [Related]
73. From empiric to mechanism-based therapy for peripheral T cell lymphoma.
Intlekofer AM; Younes A
Int J Hematol; 2014 Mar; 99(3):249-62. PubMed ID: 24510453
[TBL] [Abstract][Full Text] [Related]
74. Peripheral T-cell lymphoma with a nodular growth pattern.
Hatano B; Fukushima T; Honda M; Hayashi T; Tsuda N; Ohshima K; Tsuchiya T; Kikuchi M
Pathol Int; 2002; 52(5-6):400-5. PubMed ID: 12100523
[TBL] [Abstract][Full Text] [Related]
75. Follicular variant of peripheral T-cell lymphoma.
Lakshmanan A; Annapurneswari S; Nair S
Indian J Pathol Microbiol; 2017; 60(2):265-267. PubMed ID: 28631651
[TBL] [Abstract][Full Text] [Related]
76. Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years.
Windsor R; Stiller C; Webb D
Pediatr Blood Cancer; 2008 Apr; 50(4):784-7. PubMed ID: 18022899
[TBL] [Abstract][Full Text] [Related]
77. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
Sakata-Yanagimoto M; Chiba S
Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
[TBL] [Abstract][Full Text] [Related]
78. Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.
Vasmatzis G; Johnson SH; Knudson RA; Ketterling RP; Braggio E; Fonseca R; Viswanatha DS; Law ME; Kip NS; Ozsan N; Grebe SK; Frederick LA; Eckloff BW; Thompson EA; Kadin ME; Milosevic D; Porcher JC; Asmann YW; Smith DI; Kovtun IV; Ansell SM; Dogan A; Feldman AL
Blood; 2012 Sep; 120(11):2280-9. PubMed ID: 22855598
[TBL] [Abstract][Full Text] [Related]
79. Genotypic heterogeneity of node based peripheral T-cell lymphoma.
Smith JL; Hodges E; Howell WM; Jones DB
Leuk Lymphoma; 1993 Jul; 10(4-5):273-9. PubMed ID: 8220126
[TBL] [Abstract][Full Text] [Related]
80. Depletion of STAT5 blocks TEL-SYK-induced APMF-type leukemia with myelofibrosis and myelodysplasia in mice.
Sprissler C; Belenki D; Maurer H; Aumann K; Pfeifer D; Klein C; Müller TA; Kissel S; Hülsdünker J; Alexandrovski J; Brummer T; Jumaa H; Duyster J; Dierks C
Blood Cancer J; 2014 Aug; 4(8):e240. PubMed ID: 25148222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
